A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation

Journal of Psychopharmacology

Volumn 29, Issue 3, 2015, Pages 300-311

  McKee, Sherry A ^a,b   Potenza, Marc N ^a   Kober, Hedy ^a   Sofuoglu, Mehmet ^a,c   Arnsten, Amy F T ^a   Picciotto, Marina R ^a   Weinberger, Andrea H ^a,c   Ashare, Rebecca ^d   Sinha, Rajita ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ad libitum smoking; craving; fMRI; Guanfacine; lapse; smoking cessation; stress; Stroop

Indexed keywords

GUANFACINE; HYDROCORTISONE; PLACEBO; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DISEASE CONTROL; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE SEQUENCE; DRUG DOSE TITRATION; DRUG SAFETY; FATIGUE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMPOTENCE; INSULA; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CONTROL; SMOKING CESSATION; STRESS; STROOP TEST; SYSTOLIC BLOOD PRESSURE; TOBACCO DEPENDENCE; XEROSTOMIA; BLOOD PRESSURE; COGNITION; COMPLICATION; DRUG EFFECTS; DRUG THERAPY; MENTAL STRESS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; SMOKING; YOUNG ADULT;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; BLOOD PRESSURE; COGNITION; DOUBLE-BLIND METHOD; GUANFACINE; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREFRONTAL CORTEX; SMOKING; SMOKING CESSATION; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84924664636     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114562091     Document Type: Article

References (63)

1. al'Absi M, Hatsukami D, Davis G. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl). 2005 ; 181: 107-117
2. Arnsten AF. The use of alpha2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2010 ; 10: 1595-1605
3. Arnsten AFT. Stress signaling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009 ; 10: 410-422
4. Arnsten AFT, Cai JX, Goldman-Rakic PS. The alpha 2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: Evidence for alpha-2 receptor subtypes. J Neurosci. 1988 ; 8: 4287-4298
5. Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005 ; 26: 839-851
6. Biener L, Adams D. The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology. 1991 ; 10: 360-365
7. Botvinick M, Braver TS, Barch DM, Carter CS, Cohen JD. Conflict monitoring and cognitive control. Psychol Rev. 2001 ; 108: 624-652
8. Brewer J, Worhunsky P, Carroll K, Rounsaville B, Potenza M. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry. 2008 ; 64: 998-1004
9. Bruijnzeel AW, Bishnoi M, van Tuijl IA, et al. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats. Psychopharmacology (Berl). 2010 ; 12: 485-99
10. Buczek Y, Lê AD, Wang A, Stewart J, Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology (Berl). 1999 ; 144: 183-188
11. Carter CS, Macdonald AM, Botvinick MM, Ross LL, Stenger VA, Noll D. Parsing executive processes: Strategic vs. evaluative functions of the anterior cingulate cortex. Proc Natl Acad Sci U S A. 2000 ; 97: 1944-1948
12. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001 ; 3: 7-16
13. De Biasi M, Dani JA. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci. 2011 ; 34: 105-130
14. Del Boca FK, Kranzler HR, Brown J, Korner PF. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res. 1996 ; 20: 1412-1417
15. DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Kober H, Potenza MN. A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend. 2012 ; 122: 228-235
16. Engberg G, Eriksson E. Effects of alpha-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats. Naunyn-Schmiedeberg Arch Pharmacol. 1991 ; 343: 472-477
17. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW. Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci. 2008 ; 363: 3125-3135
18. Fiore MC, Jaén CR, Baker TB, et al Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services ; 2008 :
19. First MB, Spitzer RL, Gibbon M, Williams JB Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition. New York: Biometrics Research Department, New York State Psychiatric Institution ; 1996 :
20. Forget B, Hamon M, Thiébot MH. Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats. Psychopharmacology (Berl). 2009 ; 205: 503-515
21. Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B. Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology. 2010 ; 35: 1751-1760
22. Forray MI, Gysling K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res Brain Res Rev. 2004 ; 47: 145-160
23. Fox HC, Seo D, Tuit K, et al. Guanfacine effects on drug craving, stress arousal and prefrontal activation in cocaine dependent individuals: A preliminary investigation. J Psychopharmacol. 2012 ; 26: 957-972
24. Gourlay SG, Stead LF, Benowitz NR. Clonidine for smoking cessation. Cochrane Database Syst Rev. 2004 ; 3: CD000058
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 ; 86: 1119-1127
26. Hughes JR, Hatsukami DK. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986 ; 43: 289-294
27. Izard CE Patterns of emotions: A new analysis of anxiety and depression. London: Academic Press ; 1972 :
28. Janes AC, Pizzagalli DA, Richardt S, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010 ; 67: 722-729
29. Jastreboff AM, Sinha R, Lacadie C, Small DM, Sherwin RS, Potenza MN. Neural correlates of stress- and food-cue-induced food craving in obesity: Association with insulin levels. Diabetes Care. 2013 ; 36: 394-402
30. Jentsch JD, Wise A, Katz Z, Roth RH. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex. Synapse. 1998 ; 28: 21-26
31. Kerns J, Cohen JD, MacDonald III AW, Cho RY, Stenger VA, Carter CS. Anterior cingulate conflict monitoring and adjustments in control. Science. 2004 ; 303: 1023-1026
32. Kim S, Bobeica I, Gamo NJ, Arnsten AFT, Lee D. Effects of α-2A adrenergic receptor agonist on time and risk preference in primates. Psychopharmacology (Berl). 2012 ; 219: 363-375
33. Kober H, Mende-Siedlecki P, Kross E, et al. A prefrontal-striatal pathway underlies the cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010 ; 107: 14811-14816
34. Krishnan-Sarin S, Balodis IM, Kober H, et al. An exploratory pilot study of the relationship between neural correlates of cognitive control and reduction in cigarette use among treatment-seeking adolescent smokers. Psychol Addict Behav. 2013 ; 27: 526-532
35. Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl). 2005 ; 179: 366-373
36. Lester RA. Cognitive mechanisms underlying relapse to nicotine. Rev Neurosci. 2011 ; 22: 467-470
37. Leung H, Skudlarski P, Gatenby JC, Peterson BS, Gore JC. An event-related functional MRI study of the Stroop color word interference task. Cereb Cortex. 2000 ; 10: 552-560
38. Levine J, Schooler NR. SAFTEE: A technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986 ; 22: 343-381
39. McAllister TW, McDonald BC, Flashman LA, et al. Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: Altered working memory and BOLD response. Int J Psychophysiol. 2011 ; 82: 107-114
40. McKee SA, Maciejewski PK, Falba T, Mazure CM. Sex differences in the effects of stressful life events on changes in smoking status. Addiction. 2003 ; 98: 847-855
41. McKee SA, Sinha R, Weinberger AH, et al. Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J Psychopharmacol. 2011 ; 25: 490-502
42. McKee SA, Weinberger AH, Shi J, Tetrault J, Coppola S. Developing and validating a human laboratory model to screen medications for smoking cessation. Nicotine Tob Res. 2012 ; 14: 1362-1371
43. Smoke Free and Living It. Rochester, MN: Mayo Clinic ; 2000 :
44. Mendelson JH, Goletiani N, Sholar MB, Siegel AJ, Mello NK. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology. 2008 ; 33: 749-760
45. Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science. 2007 ; 315: 531-534
46. Physician's Desk Reference. Montvale, NJ: PDR Network ; 1994 :
47. Potenza MN, Leung H-C, Blumberg HP, et al. An fMRI Stroop study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry. 2003 ; 160: 1990-1994
48. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977 ; 1: 385-401
49. Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007 ; 28: 316-325
50. Roozendaal B, McGaugh JL. Memory modulation. Behav Neurosci. 2011 ; 125: 797-824
51. Semenova S, Markou A. The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. Eur Neuropsychopharmacol. 2010 ; 20: 731-746
52. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology (Berl). 2003 ; 168: 3-20
53. Shiffman S, Waters AJ. Negative affect and smoking lapses: A prospective analysis. J Consult Clin Psychol. 2004 ; 72: 192-201
54. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008 ; 1141: 105-130
55. Sorkin EM, Heel RC. Guanfacine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs. 1986 ; 31: 301-336
56. Stein EA, Pankiewicz J, Harsch HH, et al. Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. Am J Psychiatry. 1998 ; 155: 1009-1015
57. Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2001 ; 21: 223-228
58. Uhlen S, Wikberg JES. Delineation of rat kidney alpha 2A and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: Computer modeling reveals that guanfacine is an alpha-2A-selective compound. Eur J Pharmacol. 1991 ; 202: 235-243
59. Villégier AS, Lotfipour S, Belluzzi JD, Leslie FM. Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat. Psychopharmacology (Berl). 2007 ; 193: 457-465
60. Weinshenker D, Schroeder JP. There and back again: A tale of norepinephrine and drug addiction. Neuropsychopharmacology. 2007 ; 32: 1433-1451
61. World Health Organization (2014) http://www.who.int/campaigns/no-tobacco-day/2014/event/en/ (accessed 31 May 2014).
62. Yamada H, Bruijnzeel AW. Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats. Neuropharmacology. 2011 ; 60: 303-311
63. Yang Y, Paspalas CD, Jin LE, et al. Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex. Proc Natl Acad Sci. 2013 ; 110: 12078-83